Lunai Bioworks Statistics
Total Valuation
Lunai Bioworks has a market cap or net worth of $12.32 million. The enterprise value is $13.46 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Lunai Bioworks has 36.27 million shares outstanding. The number of shares has increased by 37.74% in one year.
| Current Share Class | 36.27M |
| Shares Outstanding | 36.27M |
| Shares Change (YoY) | +37.74% |
| Shares Change (QoQ) | +4.27% |
| Owned by Insiders (%) | 19.66% |
| Owned by Institutions (%) | 3.07% |
| Float | 26.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.26 |
Financial Efficiency
Return on equity (ROE) is -366.44% and return on invested capital (ROIC) is -20.04%.
| Return on Equity (ROE) | -366.44% |
| Return on Assets (ROA) | -13.32% |
| Return on Invested Capital (ROIC) | -20.04% |
| Return on Capital Employed (ROCE) | 94.31% |
| Weighted Average Cost of Capital (WACC) | 9.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.33M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.89% in the last 52 weeks. The beta is 0.50, so Lunai Bioworks's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -90.89% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 1.23 |
| Relative Strength Index (RSI) | 47.34 |
| Average Volume (20 Days) | 11,450,136 |
Short Selling Information
The latest short interest is 779,601, so 2.15% of the outstanding shares have been sold short.
| Short Interest | 779,601 |
| Short Previous Month | 1.51M |
| Short % of Shares Out | 2.15% |
| Short % of Float | 2.91% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.58M |
| Pretax Income | -125.52M |
| Net Income | -125.52M |
| EBITDA | -12.46M |
| EBIT | -12.58M |
| Earnings Per Share (EPS) | -$6.27 |
Full Income StatementBalance Sheet
The company has $491,645 in cash and $2.75 million in debt, giving a net cash position of -$2.26 million or -$0.06 per share.
| Cash & Cash Equivalents | 491,645 |
| Total Debt | 2.75M |
| Net Cash | -2.26M |
| Net Cash Per Share | -$0.06 |
| Equity (Book Value) | -13.55M |
| Book Value Per Share | -0.56 |
| Working Capital | -19.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.72 million and capital expenditures -$1,238, giving a free cash flow of -$5.72 million.
| Operating Cash Flow | -5.72M |
| Capital Expenditures | -1,238 |
| Depreciation & Amortization | 117,306 |
| Net Borrowing | 5.31M |
| Free Cash Flow | -5.72M |
| FCF Per Share | -$0.16 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |